Loading…
Catatonia After Low-Dose Haloperidol During Thyroid Storm: A Case Report and Systematic Review of Published Cases
Catatonia is a frequently missed diagnosis on medical wards, delaying effective treatment or permitting accidental use of neuroleptics that can exacerbate the condition. Thyroid storm has rarely been associated with catatonia in case reports, with no prior reviews synthesizing this research. We pres...
Saved in:
Published in: | Journal of the Academy of Consultation-Liaison Psychiatry 2024-11 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Catatonia is a frequently missed diagnosis on medical wards, delaying effective treatment or permitting accidental use of neuroleptics that can exacerbate the condition. Thyroid storm has rarely been associated with catatonia in case reports, with no prior reviews synthesizing this research. We present a case of catatonia during thyroid storm following administration of low-dose haloperidol followed by a review of previously published cases.
The authors first present a case of a 37-year-old woman with untreated hyperthyroidism and bipolar disorder admitted for mania in the context of thyroid storm. She developed catatonic symptoms after receiving two doses of haloperidol. The authors then present a systematic review of the literature, including OVID Medline, PsycINFO, and Embase databases, using PRISMA guidelines to identify case reports of catatonia presenting in association with hyperthyroidism.
Seventeen cases were identified-ten in published reports and seven in poster abstracts. The degree of evidence for catatonia varied, with few cases using formal scales. A minor of cases reported recent administration of neuroleptics with dopamine antagonism (29%), history of psychiatric symptoms (41%), or thyroid autoantibodies (41%). Several cases, including ours, demonstrated onset of catatonia after neuroleptic administration, usually at relatively low doses or with subsequent tolerance of neuroleptics when euthyroid.
These results are consistent with clinical and preclinical evidence that hyperthyroidism might potentiate dopamine blockade, and they encourage clinicians to minimize neuroleptic use in this population. Other theories have also been proposed for catatonia's association with hyperthyroidism, including direct thyrotoxic effect, autoimmune reaction, and mediation via another secondary psychiatric syndrome (e.g., mania). Clinicians should be aware of the potential for catatonia in thyroid storm, with or without neuroleptic use. |
---|---|
ISSN: | 2667-2960 |